These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4567423)

  • 21. [On the pathochemical characteristics of experimental nephrotic syndrome].
    Nikiforova NV
    Vopr Med Khim; 1967; 13(1):69-73. PubMed ID: 4178088
    [No Abstract]   [Full Text] [Related]  

  • 22. THE SEPARATE HYPOLIPOPROTEINEMIC EFFECTS OF DEXTROTHYROXINE AND ETHYL CHLOROPHENOXYISOBUTYRATE.
    STRISOWER EH; STRISOWER B
    J Clin Endocrinol Metab; 1964 Feb; 24():139-44. PubMed ID: 14123837
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dyslipidemias and nephropathies].
    Mioli V; Pacchiarotti P; Lombardo L; De Vizia L; Perilli A; Sprovieri G; Recchioni A; Marchesi V
    Minerva Med; 1975 Oct; 66(66):3449-53. PubMed ID: 1178135
    [No Abstract]   [Full Text] [Related]  

  • 24. Proteinuria, albumin synthesis and hyperlipidaemia in the nephrotic syndrome.
    Kaysen GA; Don B; Schambelan M
    Nephrol Dial Transplant; 1991; 6(2):141-9. PubMed ID: 1857529
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic management].
    Vanzetto G; Fouque D; Moulin B; Halimi S; Kessler M; Bayle F
    Nephrologie; 2000; 21(7):383-92. PubMed ID: 11200619
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hypolipemic agents].
    Paoletti R; Fumagalli R; Sirtori R
    Minerva Med; 1973 Apr; 64(24):1267-75. PubMed ID: 4707410
    [No Abstract]   [Full Text] [Related]  

  • 27. Hyperlipidemia of the nephrotic syndrome.
    Kaysen GA
    Kidney Int Suppl; 1991 Apr; 31():S8-15. PubMed ID: 2046275
    [No Abstract]   [Full Text] [Related]  

  • 28. Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia.
    Bridgman JF; Rosen SM; Thorp JM
    Lancet; 1972 Sep; 2(7776):506-9. PubMed ID: 4115569
    [No Abstract]   [Full Text] [Related]  

  • 29. Biochemical anomalies of the nephrotic syndrome.
    Lewith G; Gabriel R
    Curr Med Res Opin; 1975; 3(4):199-202. PubMed ID: 168035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astragalus mongholicus and Angelica sinensis compound alleviates nephrotic hyperlipidemia in rats.
    Li J; Yu L; Li N; Wang H
    Chin Med J (Engl); 2000 Apr; 113(4):310-4. PubMed ID: 11775225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein metabolism in the nephrotic syndrome.
    Warwick GL; Packard CJ
    Nephrol Dial Transplant; 1993; 8(5):385-96. PubMed ID: 8393541
    [No Abstract]   [Full Text] [Related]  

  • 32. [Diphosphonate (disodium etidronate) lowers cholesterol and total lipid levels in the blood of humans].
    Caniggia A; Gennari C; Picchi M
    Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1416-22. PubMed ID: 4218488
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hyperlipidemia in nephrotic syndrome].
    Heaf JG
    Ugeskr Laeger; 1991 Aug; 153(35):2414-6. PubMed ID: 1949240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The atherogenic potential. Critical survey on the relation between lipids and atherogenesis].
    Scandigli G; Spigai C
    G Gerontol; 1968 Apr; 16(4):347-61. PubMed ID: 4886484
    [No Abstract]   [Full Text] [Related]  

  • 35. [Characteristics of alimentary lipemia in rabbits following single-dose administration of various lipids].
    Akkerman LG; Klimov AN
    Vopr Pitan; 1967; 26(1):20-8. PubMed ID: 5611439
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of clofibrate on serum and hepatic lipids in nephrotic rats.
    Hoak JC; Connor WE; Armstrong ML; Warner ED
    Lab Invest; 1968 Oct; 19(4):370-5. PubMed ID: 5699117
    [No Abstract]   [Full Text] [Related]  

  • 37. Lipids and nephrotic syndrome.
    J Assoc Physicians India; 1972 Sep; 20(9):701-3. PubMed ID: 4654893
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of adresone and alimentary sucrose loading on blood lipids and beta-lipoprotein composition].
    Khegaĭ MD; Zharova IP
    Vopr Pitan; 1972; 31(4):63-6. PubMed ID: 4644440
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of clofibrate (Atromid S) on the thyroxine-binding capacity of thyroxine-binding globulin and free thyroxine.
    McKerron CG; Scott RL; Asper SP; Levy RI
    J Clin Endocrinol Metab; 1969 Jul; 29(7):957-61. PubMed ID: 4978385
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect on serum tocopherol levels of drug-induced decrease in serum lipids.
    Weiss P; Bianchine JR
    Am J Med Sci; 1969 Oct; 258(4):275-81. PubMed ID: 5823464
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.